The global microcrystalline cellulose market is projected to grow at a CAGR of 6.23% during 2026–2031, with Asia-Pacific emerging as the fastest-growing region, supported by expanding pharmaceutical ...

The Microcrystalline Cellulose Market size was estimated at USD 1.30 billion in 2025 and is expected to reach USD 2.61 billion by 2035, growing at a CAGR of 7.23% over the forecast period (2026-2035).

NEW YORK & DÜSSELDORF, Germany & TOKYO--(BUSINESS WIRE)-- Asahi Kasei, a diversified Japanese multinational company, has completed the construction of its second plant for Ceolus™ microcrystalline ...

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Microcrystalline Cellulose Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's ...

The direct transformation of cellulose, which is the main component of lignocellulosic biomass, into building-block chemicals is the key to establishing biomass-based sustainable chemical processes.

The growth of the market is driven by increasing pharmaceutical solid dosage form production, expanding clean-label food and beverage formulation requirements, and ...

TOKYO--(BUSINESS WIRE)--Asahi Kasei's Specialty Solutions SBU will build a second plant for microcrystalline cellulose [1] (trade name Ceolus™) at its Mizushima Works in Kurashiki, Okayama, Japan.

Asahi Kasei currently manufactures Ceolus™, a microcrystalline cellulose used primarily in pharmaceuticals as tablet binder [2], in Nobeoka, Miyazaki, Japan. Besides the standard-type product PH ...